CGP, d.d. Competitors

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc

Alvogen is a U.S. based company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products. We are passionate about making people’s lives better by making high quality medicines more accessible. The company is headquartered in Morristown, New Jersey and has more than 500 employees in the U.S. with significant in-house manufacturing capacity in Norwich, NY.